Magnetic Resonance Imaging

Leadership

Name: Leann Kania, MD
Position: Director, Magnetic Resonance Imaging

Research

The Body MRI division is engaged in numerous research projects, including:

  • Measuring hepatic lipid in nonalcoholic steatohepatitis
  • Measuring hepatic iron in systemic iron overload
  • Hepatocellular carcinoma diagnosis and treatment evaluation
  • Liver metastases: perfusion imaging to predict and evaluate early response to chemotherapy
  • Esophageal varices: accuracy of MRI compared with endoscopy
  • Hepatorenal syndrome: MRI findings
  • Ascites: MRI features of spontaneous bacterial peritonits
  • Cholangiocarcinoma: MRI features
  • Autoimmune liver disease: MRI features and differential diagnosis
  • Renal Masses: benign versus malignant based on shape of interface with the liver
  • Liver measurement: validation of linear versus volumetric measurements
  • IVC encirclement by hypertrophied caudate lobe
  • Adenomyosis: MRI and sonohysterography findings
  • Uterine fibroid embolization: MRI findings
  • Pancreatic carcinoma: appearance on MRI after surgical resection
  • Eovist: a new MRI contrast agent with renal and hepatobiliary excretion